felin
infecti
periton
fip
fatal
diseas
cat
earli
attempt
vaccin
unsuccess
even
serv
exacerb
diseas
antibodydepend
enhanc
replicationincompet
felin
foami
viru
ffv
transduc
vector
develop
potenti
vaccin
agent
immunogen
fragment
felin
coronaviru
fcov
protein
insert
use
recombin
viral
vector
express
fcov
protein
agent
chosen
apathogen
replic
incompet
within
host
follow
gene
deliveri
spumavirus
confer
sever
advantag
tradit
explor
retrovir
vector
stabl
helper
cell
line
clone
establish
transfect
crfk
cell
ffv
ta
assess
use
galactosidas
assay
pcr
immunofluoresc
western
blot
gener
infecti
virion
use
cell
line
investig
use
tasdelet
ffv
vector
contain
enhanc
green
fluoresc
protein
egfp
cassett
felin
infecti
periton
fip
fatal
diseas
cat
caus
felin
coronaviru
fcov
infect
two
serotyp
fiscu
teramoto
hohdatsu
et
al
type
preval
field
condit
hohdatsu
et
al
account
least
fip
case
howev
date
vaccin
attempt
base
serotyp
ii
develop
vaccin
larg
unsuccess
tradit
approach
sometim
serv
exacerb
diseas
antibodi
depend
enhanc
ade
identif
fcov
epitop
respons
neutralis
enhanc
still
investig
attempt
vaccin
includ
use
avirul
fcov
pedersen
black
recombin
vaccina
viru
express
protein
vennema
et
al
nonfelin
coronavirus
barlough
et
al
barlough
et
al
stoddart
et
al
plasmid
express
n
protein
alon
enhanc
vaccinia
virus
felin
cytokin
glansbeek
et
al
commerci
vaccin
christianson
et
al
launch
pfizer
anim
health
howev
safeti
remain
controversi
licens
kitten
less
week
old
mcardl
et
al
scott
et
al
gener
mucos
immun
may
critic
prevent
fcov
infect
fip
strong
cellular
immun
respons
induct
type
immun
appear
key
viru
control
review
olsen
minimis
develop
humor
antibodi
may
valuabl
avoid
ade
infect
immun
complex
deposit
express
serotyp
fcov
epitop
induc
protect
respons
use
viru
vector
differ
famili
may
provid
solut
would
reduc
risk
viru
recombin
retrovir
vector
may
act
suitabl
candid
persist
integr
provir
copi
genom
host
dna
protein
express
occur
whenev
transcript
region
initi
spumavirus
offer
sever
potenti
advantag
tradit
explor
retrovir
vector
larg
genom
size
wide
cellular
host
rang
rel
apathogen
requir
presenc
viral
transactiv
ta
high
level
transcript
viral
long
termin
repeat
ltr
latter
factor
enabl
develop
replicationincompet
delet
transactiv
prevent
transcript
structur
gene
suppli
protein
tran
via
helper
cell
line
allow
product
infecti
viral
particl
abl
infect
suscept
cell
integr
howev
infect
would
abort
unabl
produc
infecti
virion
lack
ta
target
cell
paper
describ
initi
phase
develop
felin
foami
viru
vector
investig
candid
vaccin
fip
use
tasdepend
replic
incompet
system
ffv
strain
sequenc
help
harbour
genom
organis
determin
fig
ta
amplifi
genom
polymeras
chain
reaction
pcr
gel
purifi
restrict
digest
ligat
plasmid
invitrogen
paisley
uk
standard
techniqu
posit
control
plasmid
invitrogen
contain
lac
z
gene
cmv
promot
plasmid
grown
escherichia
coli
purifi
endotoxinfre
endofre
plasmid
maxi
kit
qiagen
crawley
uk
confirm
integr
plasmid
achiev
pcr
restrict
digest
lacz
product
visualis
agaros
gel
electrophoresi
function
plasmid
investig
transfect
assay
galactosidas
stain
cation
lipidbas
transfect
system
lipofectamin
invitrogen
use
carri
plasmid
dna
fkcultr
zeo
gal
report
cell
kind
gift
prof
rethwilm
univers
wurzburg
germani
cell
contain
lacz
gene
control
ffv
ltr
product
function
ta
transfect
cell
would
result
transcript
lacz
gene
galactosidas
produc
catalys
hydrolysi
galactosid
substrat
xgal
dgalactopyranosid
produc
blue
colour
product
cleav
galactosidas
visualis
light
microscopi
crfk
cell
transfect
plasmid
optimis
assay
posit
cell
select
antibiot
resist
serial
dilut
obtain
singl
cell
clone
parallel
ltr
gag
env
pol
figur
diagrammat
represent
felin
foami
viru
ffv
genom
ffv
typic
retrovir
organis
consist
ltr
main
structur
gene
gag
pol
env
also
contain
two
accessori
open
read
frame
compar
prototyp
simian
foami
virus
three
ta
encod
viral
transactiv
ta
drive
tempor
express
intern
promot
ip
end
env
ltr
promot
bet
produc
splice
protein
region
ta
indic
crfk
cell
transfect
gal
dilut
clone
grown
week
stain
assess
effect
procedur
singl
cell
clone
gener
analys
immunofluoresc
pcr
transfect
assay
second
report
plasmid
use
purpos
ffv
galzeo
kind
gift
prof
rethwilm
contain
lacz
gene
control
ffv
promot
helper
cell
line
clone
express
function
ta
ltr
promot
would
activ
would
allow
express
lacz
gene
galactosidas
product
could
assess
standard
colourimetr
assay
crfk
cell
transfect
parallel
act
neg
control
vector
construct
contain
egfp
gene
place
viral
transactiv
use
investig
packag
abil
gener
virion
abl
infect
felin
cell
vector
transfect
helper
cell
use
lipofectamin
invitrogen
cell
passag
monitor
egfp
fluoresc
optimis
transfect
method
result
transfect
effici
averag
fig
helper
cell
line
clone
crfkta
develop
period
cell
clone
grown
confluenc
expand
test
frozen
stock
thirtytwo
crfkta
singl
cell
clone
identifi
seven
clone
found
express
function
ta
effici
rang
fig
pcr
function
helper
cell
line
clone
presenc
ta
gene
insert
reveal
posit
bp
band
consist
expect
size
ta
gene
homogen
express
helper
cell
line
subsequ
assess
studi
ta
underway
helper
cell
line
transfect
replicationincompet
tasdelet
vector
contain
egfp
gene
cassett
fluoresc
detect
cell
use
invert
fluoresc
microscop
abil
vector
replic
helper
cell
line
transfer
independ
cell
cultur
investig
viral
vector
develop
human
gene
therapi
applic
recent
year
though
mani
current
vehicl
remain
either
ineffici
potenti
unsaf
uniqu
biolog
foami
virus
lend
develop
vector
particularli
report
lack
pathogen
human
zoonot
infect
simian
fv
sfv
report
thought
human
fv
renam
prototyp
p
fv
origin
zoonot
infect
sfvcpz
herchenrod
et
al
sfv
infect
man
report
apathogen
studi
involv
monitor
period
man
appear
deadend
host
henein
et
al
despit
link
number
diseas
includ
de
quervain
thyroid
werner
gelderblom
grave
diseas
lagay
et
al
diseas
et
al
studi
subsequ
confirm
associ
review
henein
et
al
report
associ
ffv
felin
polyarthropathi
pedersen
et
al
cofactor
effect
fiv
winkler
et
al
zenger
et
al
report
confirm
worker
field
convinc
evid
direct
patholog
associ
infect
studi
shown
ffv
rel
ubiquit
domest
feral
cat
popul
seropreval
rang
popul
bandecchi
et
al
flower
et
al
winkler
et
al
winkler
et
al
winkler
et
al
conclud
phylogenet
analys
simian
foami
virus
long
histori
coexist
coevolut
host
herchenrod
et
al
schweizer
neumannhaefelin
may
appli
ffv
cat
experiment
infect
cat
provid
evid
patholog
clinic
sign
diseas
alk
et
al
schwant
et
al
thu
although
issu
pathogen
complet
rule
evid
suggest
viru
nonpathogen
current
investig
possibl
pathogen
associ
ffv
experiment
infect
cat
paper
describ
initi
phase
product
tasdelet
replic
incompet
vector
system
reliant
ta
packag
cell
line
work
date
produc
function
homogen
crfkta
helper
cell
line
current
work
assess
function
egfp
contain
vector
preliminari
result
indic
failur
passag
vector
despit
adequ
transfect
effici
could
due
packag
problem
bp
delet
ta
fragment
replac
kb
egfp
cassett
altern
disrupt
bet
splice
protein
produc
high
level
viral
replic
see
fig
due
ta
delet
may
respons
bet
shown
indispens
vitro
ffv
replic
alk
et
al
current
studi
look
suppli
bet
tran
reduc
foreign
gene
insert
size
investig
issu
variou
phase
fv
vector
develop
worker
date
initi
work
look
tasdelet
system
accessori
env
replac
report
gene
gene
interest
ta
suppli
tran
bieniasz
et
al
russel
miller
replic
compet
vector
produc
substitut
gene
gene
interest
retain
ta
schmidt
rethwilm
insert
gene
express
fusion
protein
bet
either
code
sequenc
selfcleav
fmd
viru
proteas
intern
ribosom
entri
site
allow
recombin
protein
product
foreign
gene
place
control
heterolog
promot
enabl
high
level
express
recent
vector
develop
replac
region
ltr
cmv
promot
allow
tasindepend
vector
product
high
level
trobridg
russel
revers
transcript
restor
produc
doubl
strand
vector
dna
integr
viru
tasdelet
viral
replic
addit
delet
ta
respons
element
tata
box
region
elimin
risk
activ
fv
promot
cellular
compon
heinkelein
et
al
final
minim
construct
vector
produc
use
pfv
depend
cotransfect
system
suppli
gag
pol
env
tran
trobridg
et
al
ffv
appear
difficult
manipul
pfv
vector
develop
strike
biolog
differ
two
virus
particularli
absolut
requir
bet
ffv
replic
alk
et
al
howev
ffv
vector
develop
appli
recent
experiment
studi
look
vaccin
felin
caliciviru
schwant
et
al
applic
vector
tackl
problem
vaccin
develop
fip
new
approach
aim
potenti
cell
mediat
immun
respons
provid
persist
protect
face
high
environment
fcov
load
develop
vector
system
requir
identif
clone
coronaviru
epitop
neutralis
enhanc
use
fcov
serotyp
strain
enabl
characteris
fcov
antigen
like
give
effect
vaccin
respons
construct
assess
ffvfcov
antigen
vector
allow
determin
valu
construct
potenti
vaccin
thu
ffv
shown
potenti
develop
viral
vector
vaccin
fip
use
vector
excit
applic
gene
therapi
technolog
cat
sinc
new
area
biotechnolog
felin
medicin
investig
issu
biosafeti
applic
need
investig
technolog
becom
avail
clinician
